The AHRQ PSNet Collection comprises an extensive selection of resources relevant to the patient safety community. These resources come in a variety of formats, including literature, research, tools, and Web sites. Resources are identified using the National Library of Medicine’s Medline database, various news and content aggregators, and the expertise of the AHRQ PSNet editorial and technical teams.
Vaccine errors can hinder immunization efforts in the United States. In this article, the authors summarize errors involving 2-component vaccines, discuss safe practices for storing, preparing, dispensing, and administering 2-component vaccines, and highlight risk reduction strategies.
Bjerre LM, Parlow S, de Launay D, et al. BMJ Open. 2018;8:e020150.
In this cross-sectional study, researchers evaluated medication safety letters issued by Health Canada, the United States Food and Drug Administration, and the United Kingdom Medicines and Healthcare products Regulatory Agency over a 4-year period to evaluate consistency of structure and content as well as timing and commonality of subject matter. They found significant differences in the medication safety letters issued by all three agencies with regard to both the timing and the focus. The authors suggest that better coordination across these bodies might improve patient safety.
Moore TJ, Furberg CD, Mattison DR, et al. Pharmacoepidemiol Drug Saf. 2016;25:713-8.
According to this study, many adverse drug event reports submitted by drug manufacturers to the Food and Drug Administration were incomplete. The authors advocate for the FDA to update their reporting requirements and compliance policies.
Cohen MR, Smetzer JL, Westphal JE, et al. J Am Pharm Assoc (2003). 2012;52:584-602.
Sociotechnical probabilistic risk assessment—a prospective method of identifying potential patient safety hazards—was used to assess the risk for medication errors in community pharmacies.
This commentary discusses the importance of handoff communication in ensuring safe transfers and recommends that mental models be developed within the care team to improve handoff safety.
Cohen MD, Hilligoss B. Qual Saf Health Care. 2010;19:493-7.
This review highlights gaps in the current literature on handoffs, which include inadequate research supporting best practices in the context of growing mandates to do so.
This monthly column highlights an initiative to introduce safer device connectors to prevent spinal and epidural medications from being delivered intravenously, discusses the value of independent double-checks, and shares thoughts on the 35th anniversary of this column.
Smetzer JL, Baker C, Byrne FD, et al. Jt Comm J Qual Patient Saf. 2010;36:152-163.
This article discusses how a hospital responded to a fatal medication error that occurred when a nurse mistakenly administered epidural pain medication intravenously to a pregnant teenager. Findings from the root cause analysis of the error revealed underlying factors including fatigue (the nurse had worked a double shift the day before), failed safety systems (the hospital had recently implemented a bar coding system, but not all nurses were trained and workarounds were routine), and human factors engineering (bags containing antibiotics and pain medications were similar in appearance and could be accessed with the same type of catheter). A range of safety interventions were implemented as a result. However, the related editorials by leaders in the safety field (Drs. Sidney Dekker, Charles Denham, and Lucian Leape) take the hospital to task for focusing on narrow improvements rather than using complexity theory to solve underlying problems, and for creating a "second victim" by disciplining the nurse (who was fired and ultimately criminally prosecuted) rather than acknowledging the institution's responsibility and the caregiver's emotional distress. The article and commentaries provide a fascinating, in-depth look at the true impact of a never event.
Moore TJ, Cohen MR, Furberg CD. Arch Intern Med. 2007;167:1752-9.
Voluntarily reported adverse drug events increased markedly from 1998-2005, with a small proportion of drugs accounting for a disproportionate share of adverse events.